How to build a tumor: An industry perspective
Author:
Funder
Horizon 2020
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference66 articles.
1. The Future of Clinical Trial Design in Oncology;Spreafico;Cancer Discov,2021
2. Impact of a five-dimensional framework on R&D productivity at AstraZeneca;Morgan;Nat Rev Drug Discov,2018
3. When failure should be the option;Petsko;BMC Biol,2010
4. Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs;Gerdes;Nat Commun,2021
5. NCI-60 Cell Line Screening: A Radical Departure in its Time;Chabner;J Natl Cancer Inst,2016
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advances in cancer mechanobiology: Metastasis, mechanics, and materials;APL Bioengineering;2024-03-01
2. Sensor extended imaging workflow for creating fit for purpose models in basic and applied cell biology;Communications Biology;2024-02-10
3. Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment;Biomedicines;2023-03-30
4. 3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures;Pathology and Oncology Research;2023-02-09
5. Tumor Organoids as a Research Tool: How to Exploit Them;Cells;2022-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3